FDA panels support LGF for emergency use

FDA's Medical Imaging Drug Advisory Committee and Oncologic Drugs Advisory Committee voted 17-1 that use of leukocyte growth factors (LGFs) to treat radiation-induced myelosuppression is "reasonably l...